Sandra M Lord (Sandra Lord)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Clinical Practice

Cardiovascular Disease

Top Venues

The Journal of clinical endocrinology and metabolism

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Stephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, Megan Smithmyer, Christine Bender, Cate Speake, Sandra M Lord, Carla J Greenbaum
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes. The Journal of clinical endocrinology and metabolism (2024)
Stephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, Megan Smithmyer, Christine Bender, Cate Speake, Sandra M Lord, Carla J Greenbaum
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes. The Journal of clinical endocrinology and metabolism (2024)
Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, Darrell M Wilson, Andrea K Steck, Jennifer L Sherr, Jason L Gaglia, Christine Bender, Sandra M Lord, Carla J Greenbaum
OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals. The Journal of clinical endocrinology and metabolism (2023)
Sandra M Lord, Henry T Bahnson, Carla J Greenbaum, David R Liljenquist, John Virostko, Cate Speake
Testing a new platform to screen disease-modifying therapy in type 1 diabetes. PloS one 18 (12) (2023)
Yevgeniy Yuzefpolskiy, Peter A Morawski, Mitchell L Fahning, Cate Speake, Sandra M Lord, Anu Chaudhary, Chihiro Morishima, Mark H Wener, Mariko Kita, Lucas McCarthy, Jane H Buckner, Daniel J Campbell, Estelle Bettelli
Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients. Journal of immunology (Baltimore, Md. : 1950) 208 (7) (2022)